Citation advantage of COVID-19-related publications

被引:5
|
作者
Liu, Weishu [1 ]
Huangfu, Xuping [1 ]
Wang, Haifeng [2 ]
机构
[1] Zhejiang Univ Finance & Econ, Sch Informat Management & Artificial Intelligence, Hangzhou, Peoples R China
[2] Shanghai Int Studies Univ, Sch Business & Management, Shanghai 200083, Peoples R China
基金
中国国家自然科学基金;
关键词
Bibliometric analysis; citation advantage; COVID-19; highly cited paper; Web of Science; UNITED-STATES; IMPACT FACTOR; CHINA; ARTICLES;
D O I
10.1177/01655515231174385
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
With the global spread of the COVID-19 pandemic, scientists from various disciplines responded quickly to this historical public health emergency. The sudden boom of COVID-19-related papers in a short period of time may bring unexpected influence to some commonly used bibliometric indicators. By a large-scale investigation using Science Citation Index Expanded and Social Sciences Citation Index, this brief communication confirms the citation advantage of COVID-19-related papers empirically through the lens of Essential Science Indicators' highly cited paper. More than 8% of COVID-19-related papers published during 2020 and 2021 were selected as Essential Science Indicators highly cited papers, which was much higher than the set global benchmark value of 1%. The citation advantage of COVID-19-related papers for different Web of Science categories/countries/journal impact factor quartiles was also demonstrated. The distortions of COVID-19-related papers' citation advantage to some bibliometric indicators such as journal impact factor were discussed at the end of this brief communication.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Intricate scientometric analysis and citation trend of COVID-19-related publications in Indian Journal of Ophthalmology during COVID-19 pandemic
    Kaur, Kirandeep
    Gurnani, Bharat
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (08) : 2202 - 2210
  • [2] Methodological Issues in COVID-19-Related Publications During the Pandemic
    Cakir, Banu
    KLIMIK JOURNAL, 2022, 35 (04) : 209 - 214
  • [3] Comparative Advantage and Competitiveness of COVID-19-Related Medical Products Exporters
    Idris, Zera Zuryana
    Ismail, Normaz Wana
    Ibrahim, Saifuzzaman
    JOURNAL OF COMPETITIVENESS, 2022, 14 (01) : 61 - 79
  • [4] COVID-19-related cholecystitis
    Famularo, Giuseppe
    Spada, Pier Luigi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [5] COVID-19-Related Stroke
    David C. Hess
    Wael Eldahshan
    Elizabeth Rutkowski
    Translational Stroke Research, 2020, 11 : 322 - 325
  • [6] COVID-19-Related Stroke
    Hess, David C.
    Eldahshan, Wael
    Rutkowski, Elizabeth
    TRANSLATIONAL STROKE RESEARCH, 2020, 11 (03) : 322 - 325
  • [7] Bibliometric evaluation of 2020-2022 publications on COVID-19-related cardiovascular disease
    Chen, Yiru
    Cao, Buzi
    Zhou, Quan
    Liu, Yantong
    He, Qingnan
    Zhao, Mingyi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [8] COVID-19-Related Myocarditis: Are We There Yet? A Case Report of COVID-19-Related Fulminant Myocarditis
    Pierri, Alessandro
    Gagno, Giulia
    Fluca, Alessandra
    Radaelli, Davide
    Bonuccelli, Diana
    Giusti, Laura
    Bulfoni, Michela
    Beltrami, Antonio P.
    Aleksova, Aneta
    D'Errico, Stefano
    BIOMEDICINES, 2023, 11 (08)
  • [9] Iloprost for COVID-19-related vasculopathy
    Moezinia, Carine J.
    Ji-Xu, Antonio
    Azari, Arianna
    Horlick, Serena
    Denton, Christopher
    Stratton, Richard
    LANCET RHEUMATOLOGY, 2020, 2 (10): : E582 - E583
  • [10] COVID-19-related IgA vasculitis
    Allez, Matthieu
    Denis, Blandine
    Bouaziz, Jean-David
    Battistella, Maxime
    Zagdanski, Anne-Marie
    Bayart, Jules
    Lazaridou, Ingrid
    Gatey, Caroline
    Pillebout, Evangeline
    Chaix Baudier, Marie-Laure
    Delaugerre, Constance
    Molina, Jean-Michel
    Le Goff, Jerome
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (11) : 1952 - 1953